Lista de

agonists
9
"Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys" (2018) Abiuso, A.M.B.;Varela, M.L.;Haro Durand, L. (...)Mondillo, C. European Journal of Cancer. 91:125-135
"Synthesis and activity evaluation of a series of cholanamides as modulators of the liver X receptors" (2018) Martínez, M.D.;Ghini, A.A.;Dansey, M.V. (...)Burton, G. Bioorganic and Medicinal Chemistry. 26(5):1092-1101
"Fluorinated oxysterol analogues: Synthesis, molecular modelling and LXRβ activity" (2017) Rodriguez, C.R.;Alvarez, L.D.;Dansey, M.V. (...)Burton, G. Journal of Steroid Biochemistry and Molecular Biology. 165:268-276
"Hypothalamic POMC deficiency improves glucose tolerance despite insulin resistance by increasing Glycosuria" (2016) Chhabra, K.H.;Adams, J.M.;Fagel, B. (...)Low, M.J. Diabetes. 65(3):660-672
"C(16)-C(22) oxygen-bridged analogues of ceDAF-12 and LXR ligands" (2016) Del Fueyo, M.C.;Dansey, M.V.;Paolo, L.S. (...)Burton, G. Steroids. 112:109-114
"Neuromodulation of the luteal regression: Presence of progesterone receptors in coeliac ganglion" (2015) Ghersa, F.;Burdisso, J.;Vallcaneras, S.S. (...)Casais, M. Experimental Physiology. 100(8):935-946
"Agonist mobility on supported lipid bilayers affects Fas mediated death response" (2015) Sánchez, M.F.; Levi, V.; Weidemann, T.; Carrer, D.C. FEBS Letters. 589(23):3527-3533
"Astroglial mGlu3 receptors promote alpha-secretase-mediated amyloid precursor protein cleavage" (2014) Durand, D.;Carniglia, L.;Beauquis, J. (...)Lasaga, M. Neuropharmacology. 79:180-189
"Molecular basis of mineralocorticoid receptor action in the nervous system" (2013) Molinari, A.M.;Machado-Rada, M.Y.;Mazaira, G.I. (...)Galigniana, M.D. CNS and Neurological Disorders - Drug Targets. 12(8):1163-1174